199 related articles for article (PubMed ID: 21115465)
1. Beyond Raynaud's phenomenon hides very early systemic sclerosis: the assessment of organ involvement is always mandatory.
Czirják L; Matucci-Cerinic M
Rheumatology (Oxford); 2011 Feb; 50(2):250-1. PubMed ID: 21115465
[No Abstract] [Full Text] [Related]
2. Plasma beta-thromboglobulin in the differential diagnosis of Raynaud's phenomenon.
Seibold JR; Harris JN
J Rheumatol; 1985 Feb; 12(1):99-103. PubMed ID: 2580093
[TBL] [Abstract][Full Text] [Related]
3. Clinical implications from capillaroscopic analysis in patients with Raynaud's phenomenon and systemic sclerosis.
Herrick AL; Cutolo M
Arthritis Rheum; 2010 Sep; 62(9):2595-604. PubMed ID: 20506306
[No Abstract] [Full Text] [Related]
4. Improving outcome prediction of systemic sclerosis from isolated Raynaud's phenomenon: role of autoantibodies and nail-fold capillaroscopy.
Ingegnoli F; Boracchi P; Gualtierotti R; Biganzoli EM; Zeni S; Lubatti C; Fantini F
Rheumatology (Oxford); 2010 Apr; 49(4):797-805. PubMed ID: 20100796
[TBL] [Abstract][Full Text] [Related]
5. [Esophageal motility in Raynaud's disease, systemic scleroderma and presclerodermal Raynaud's syndrome].
Hostein J; Bost R; Carpentier P; Franco A; Fournet J
Gastroenterol Clin Biol; 1985 Feb; 9(2):130-5. PubMed ID: 3979734
[TBL] [Abstract][Full Text] [Related]
6. Raynaud's phenomenon, scleroderma, overlap syndromes, and other fibrosing syndromes.
Clements PJ
Curr Opin Rheumatol; 1994 Nov; 6(6):603-6. PubMed ID: 7865380
[No Abstract] [Full Text] [Related]
7. Raynaud's phenomenon.
Wigley FM; Flavahan NA
Rheum Dis Clin North Am; 1996 Nov; 22(4):765-81. PubMed ID: 8923595
[TBL] [Abstract][Full Text] [Related]
8. Raynaud's phenomenon and systemic sclerosis.
Generini S; Kahaleh B; Matucci-Cerinic M; Pignone A; Lombardi A; Ohtsuka T
Ann Ital Med Int; 1996; 11(2):125-31. PubMed ID: 8974438
[TBL] [Abstract][Full Text] [Related]
9. [Capillaroscopy and vascular acrosyndromes].
Planchon B; Pistorius MA
J Mal Vasc; 1999 Dec; 24(5):357-62. PubMed ID: 10642647
[TBL] [Abstract][Full Text] [Related]
10. Quantifying digital vascular disease in patients with primary Raynaud's phenomenon and systemic sclerosis.
Herrick AL; Clark S
Ann Rheum Dis; 1998 Feb; 57(2):70-8. PubMed ID: 9613334
[No Abstract] [Full Text] [Related]
11. Raynaud's phenomenon and scleroderma.
Harper FE; LeRoy EC
Compr Ther; 1981 Feb; 7(2):45-51. PubMed ID: 6163587
[No Abstract] [Full Text] [Related]
12. Digital pressure responses to cooling in patients with suspected early vs definite scleroderma (systemic sclerosis) vs primary Raynaud's phenomenon.
Maricq HR; Diat F; Weinrich MC; Maricq JG
J Rheumatol; 1994 Aug; 21(8):1472-6. PubMed ID: 7983649
[TBL] [Abstract][Full Text] [Related]
13. [Raynaud's syndrome and scleroderma. I. Scleroderma-like changes in Raynaud's syndrome and their differentiation from scleroderma].
JABLONSKA S; LUKASIAK B; BUBNOW B
Pol Tyg Lek (Wars); 1957 Sep; 12(39):1481-6. PubMed ID: 13505250
[No Abstract] [Full Text] [Related]
14. Capillaroscopy.
Cutolo M; Pizzorni C; Secchi ME; Sulli A
Best Pract Res Clin Rheumatol; 2008 Dec; 22(6):1093-108. PubMed ID: 19041079
[TBL] [Abstract][Full Text] [Related]
15. The differential diagnosis of Raynaud's phenomenon.
Wigley FM
Hosp Pract (Off Ed); 1991 Jul; 26(7):63-70, 73-84. PubMed ID: 2071684
[No Abstract] [Full Text] [Related]
16. Raynaud's phenomenon and other features of scleroderma, including pulmonary hypertension.
Wigley FM
Curr Opin Rheumatol; 1996 Nov; 8(6):561-8. PubMed ID: 9018460
[TBL] [Abstract][Full Text] [Related]
17. [Raynaud's phenomena: diagnostic and treatment study].
Priollet P
Rev Prat; 1998 Oct; 48(15):1659-64. PubMed ID: 9814067
[TBL] [Abstract][Full Text] [Related]
18. Early systemic sclerosis: assessment of clinical and pre-clinical organ involvement in patients with different disease features.
Valentini G; Cuomo G; Abignano G; Petrillo A; Vettori S; Capasso A; Cozzolino D; Del Genio G; Santoriello C
Rheumatology (Oxford); 2011 Feb; 50(2):317-23. PubMed ID: 20562195
[TBL] [Abstract][Full Text] [Related]
19. Laser Doppler skin perfusion pressure in the assessment of Raynaud's phenomenon.
Kanetaka T; Komiyama T; Onozuka A; Miyata T; Shigematsu H
Eur J Vasc Endovasc Surg; 2004 Apr; 27(4):414-6. PubMed ID: 15015193
[TBL] [Abstract][Full Text] [Related]
20. [Esophageal motility, systemic scleroderma and Raynaud's phenomenon].
Gosselin A
Gastroenterol Clin Biol; 1985 Feb; 9(2):127-9. PubMed ID: 3979733
[No Abstract] [Full Text] [Related]
[Next] [New Search]
